Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 0/1 Randomized Clinical Trial of SENIcapoc and PERAmpanel Mono- and Combination Therapy of Newly Diagnosed Glioblastoma

NCT07284069 is registered in ClinicalTrials.gov with Aarhus University Hospital as lead sponsor.

NCT NCT07284069
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07284069 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 0/1 Randomized Clinical Trial of SENIcapoc and PERAmpanel Mono- and Combination Therapy of Newly Diagnosed Glioblastoma
Lead sponsor
Aarhus University Hospital
Phase
Phase 1
Overall status
Recruiting
Start date
March 1, 2026
Completion date
November 1, 2028
Enrollment
36 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glioblastoma